Meet our panel of medical specialists

Research Review Australia works with over 70 local medical specialists to select and advise on the most important research from around the world. They advise on what really matters, what impact it has on local healthcare and what we need to do in our daily practice to accomodate new skills and knowledge. Select a category below to see more about each of our expert advisors.

Dr Chanukya Colonne

Dr Chanukya Colonne

Chan is a physician-scientist based in Sydney, specialising in CAR-T cell therapy and immuno-oncology, with a focus on advancing treatments for acute myeloid leukaemia (AML). She completed her specialist haematology training at Westmead and Royal Prince Alfred Hospitals, where she gained hands-on experience in the clinical implementation and delivery of CAR-T therapies. Currently, Chan is a postdoctoral research fellow in Professor Cameron Turtle’s laboratory at the University of Sydney, developing next-generation CAR-T cell therapies for AML. Alongside her research, she serves as a clinical trials fellow at Royal North Shore Hospital, helping translate cutting-edge therapies into patient care... read more »

Dr Salvatore (Sam) Fiorenza

Dr Salvatore (Sam) Fiorenza

Sam is a physician-scientist and CAR(-T) enthusiast (he drives a Corolla). He is the Medical Lead of Cell Therapy at Epworth HealthCare where he is also a clinical haematologist with an interest in malignant disease and immunotherapy. He is also a staff specialist at the Alfred Hospital in the CAR-T and lymphoma team where he will be assisting with new cellular therapy studies arising from the Paula Fox Melanoma and Cancer Centre. Sam is a senior research fellow with Professor Cameron Turtle at the University of Sydney where his research interest is in using high-dimensional analyses to parse determinants of CAR-T cell therapy. During his post-doctoral studies at the Fred Hutchinson Cancer Center in Seattle, his broad research activity included the epigenomic basis of CAR-T cell fitness, novel CAR-T cell therapies for AML, understanding how the microbiome impacts T cell reconstitution following allogeneic stem cell transplantation and the value and affordability of CAR-T cell therapy. .. read more »